RecruitingNCT07441785

Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer


Sponsor

P. Herzen Moscow Oncology Research Institute

Enrollment

400 participants

Start Date

Jan 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Proximal gastric and esophagogastric junction cancers comprise up to 40% of gastric malignancies. For localized disease, proximal gastrectomy is the main radical procedure, but reconstruction of GI tract often leads to significant functional issues. Rising use of proximal resections and broader indications have increased attention to postoperative quality of life (QoL). Common reconstructions include direct esophagogastrostomy (various types), double-tract reconstruction, jejunal interposition, and newer anti-reflux anastomoses (e.g., double-flap, overlap, tunnel techniques). Each method has unique pros and cons regarding reflux esophagitis, food passage, dumping syndrome, nutritional changes, and long-term QoL. No consensus exists on the optimal technique, leading to variable practices and outcomes. Most research focuses on oncologic radicality and survival, while functional results and QoL remain understudied. Systematic evaluation of functional outcomes across reconstruction types after proximal subtotal gastrectomy is needed in Russian Federation to improve QoL, advance research, and standardize treatment of proximal gastric and EGJ cancers.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing different surgical reconstruction techniques used after proximal gastrectomy — an operation that removes the upper part of the stomach — for cancer of the stomach or the area where the stomach meets the esophagus (food pipe). Researchers want to know which reconstruction method produces the best functional outcomes and recovery. **You may be eligible if...** - You have confirmed stomach or esophagogastric junction cancer (including Siewert I or II types) - You are undergoing surgery to remove the upper portion of the stomach with the intent to cure, between January 2025 and December 2026 - Surgery may be open, laparoscopic, or robotic **You may NOT be eligible if...** - Your cancer has spread to other organs (including positive fluid biopsy of the abdomen) - You have Siewert type I cancer (a specific location at the top of the esophagogastric junction) - You are having emergency surgery or surgery without intent to cure - You are having additional surgeries for another esophageal or esophagogastric cancer at the same time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREProximal Gastrectomy

Resection of the upper third to one-half of the stomach and the distal portion of the esophagus with different types of digestive system reconstruction


Locations(1)

P.Herzen Moscow Oncological Research Institute

Moscow, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07441785


Related Trials